Level Biotechnology Inc. (3118.TWO)

TWD 32.0

(0.0%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 660.61 Million 593.01 Million 677.27 Million 672.49 Million 638.9 Million
Cost of Revenue 441.06 Million 390.42 Million 444.77 Million 460.77 Million 452.93 Million
Gross Profit 219.54 Million 202.59 Million 232.5 Million 211.71 Million 185.97 Million
Operating Expenses 151.99 Million 137.68 Million 153.54 Million 145.55 Million 129.52 Million
Selling, General and Administrative Expenses 138.22 Million 123.65 Million 138.51 Million 131.85 Million 119.33 Million
Research and Development Expenses 13.77 Million 14.03 Million 15.02 Million 13.69 Million 10.18 Million
Other Expenses - 6.12 Million 3.12 Million 2.71 Million -
Cost and Expenses 593.05 Million 528.1 Million 598.31 Million 606.33 Million 582.45 Million
Operating Income 67.55 Million 73.5 Million 85.4 Million 73.13 Million 56.44 Million
Interest Expense 332 Thousand 348 Thousand 378 Thousand 434 Thousand 469 Thousand
Income Tax Expense 15.74 Million 14.69 Million 16.71 Million 14.5 Million 11.97 Million
Earnings before Tax 78.65 Million 73.15 Million 84.89 Million 72.54 Million 59.36 Million
Net Income 62.9 Million 58.46 Million 68.17 Million 58.04 Million 47.39 Million
Earnings Per Share Basic 1.94 1.80 2.10 1.79 1.46
Earnings Per Share Diluted 1.93 1.79 2.09 1.78 1.45
Weighted Average Shares Outstanding 32.45 Million 32.45 Million 32.45 Million 32.45 Million 32.45 Million
Weighted Average Shares Outstanding (Diluted) 32.65 Million 32.66 Million 32.66 Million 32.6 Million 32.59 Million
Gross Margin 0.33 0.34 0.34 0.31 0.29
EBIT Margin 0.15 0.16 0.16 0.14 0.13
Profit Margin 0.10 0.10 0.10 0.09 0.07
EBITDA 98.7 Million 93 Million 105.06 Million 93.96 Million 80.16 Million
Earnings Before Tax Margin 0.10 0.12 0.13 0.11 0.09

Income Statement Charts